Literature DB >> 189899

Differential recovery of intestine, bone marrow, and thymus of rats with solid tumors following 5-fluorouracil administration.

H A Hopkins, C J Kovacs, W B Looney, J A Wakefield.   

Abstract

Time relationships for recovery of several host organs from toxic effects of 5-fluorouracil were determined in ACI rats bearing Morris hepatoma 3924A. A single injection of 150 mg/kg body weight 5-fluorouracil (the LD10) resulted in loss of 90% of the tibial bone marrow, 60% of the intestinal mucosa, and 90% of the thymus as measured by total DNA content of the organs. Organ DNA contents following 150 mg/kg of the drug were minimal on day 3 for intestine and on day 5 for marrow and thymus. A return to pretreatment or higher levels of DNA was observed by day 4 for intestine, day 11 for tibial marrow, and day 19 for thymus. Incorporation of 3H-deoxyuridine into host organ DNA after 150 mg/kg 5-fluorouracil was inhibited 36 hrs for intestine, 3 days for thymus, and 5 days for tibial bone marrow. Inhibition of 3H-deoxyuridine incorporation into DNA was similar for 50, 100, and 150 mg/kg doses both in tumor and in host organs, but recovery of 3H-deoxyuridine incorporation and DNA content of host organs began later with the higher doses of 5-fluorouracil. Maximal incorporation of 3H-deoxyuridine into DNA was observed on day 4 for intestine, day 8 for marrow, and day 9 for thymus after treatment with 150 mg/kg 5-fluorouracil. Animal lethality following the second of two 150 mg/kg injections of 5-fluorouracil was related to the extent of recovery of intestinal mucosa and bone marrow at the time of the second injection. Survival decreased to 0% for normal rats when the interval between injections was 3-4 days, improved at 5 days and was 100% when the interval was 10-11 days.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 189899

Source DB:  PubMed          Journal:  Cancer Biochem Biophys        ISSN: 0305-7232


  4 in total

1.  Solid tumor models for assessment of different treatment modalities: therapeutic strategy for sequential chemotherapy with radiotherapy.

Authors:  W B Looney; J S Trefil; H A Hopkins; C J Kovacs; R Ritenour; J G Schaffner
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

2.  Solid tumour models for the assessment of different treatment modalities: VII: single vs fractionated doses of 5-fluorouracil on two solid tumours and their hosts.

Authors:  W B Looney; M S Macleod; H A Hopkins
Journal:  Br J Cancer       Date:  1978-05       Impact factor: 7.640

3.  Response kinetics of host and experimental solid tumour after adriamycin.

Authors:  H A Hopkins; W B Looney; K Teja; A S Hobson; M S MacLeod
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

4.  Response and recovery kinetics of a solid tumour after irradiation.

Authors:  R Rowley; H A Hopkins; W L Betsill; E R Ritenour; W B Looney
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.